Gold nanoparticles and electroporation impose both separate and synergistic radiosensitizing effects in HT-29 tumor cells: an in vitro study

被引:36
作者
Rezaee, Zohre [1 ,2 ]
Yadollahpour, Ali [1 ,2 ]
Bayati, Vahid [1 ]
Dehbashi, Fereshteh Negad [1 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Avhaz, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Med Phys, Golestan Blvd, Ahvaz 6135733118, Iran
来源
INTERNATIONAL JOURNAL OF NANOMEDICINE | 2017年 / 12卷
关键词
gold nanoparticles; radiosensitizer; electroporation; dose enhancement factor; synergistic effect; DOSE ENHANCEMENT; CANCER-CELLS; RADIATION CYTOTOXICITY; MAMMALIAN-CELLS; SIZE; GENERATION; DELIVERY; DNA;
D O I
10.2147/IJN.S128996
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Background and objective: Radiation therapy (RT) is the gold standard treatment for more than half of known tumors. Despite recent improvements in RT efficiency, the side effects of ionizing radiation (IR) in normal tissues are a dose-limiting factor that restricts higher doses in tumor treatment. One approach to enhance the efficiency of RT is the application of radiosensitizers to selectively increase the dose at the tumor site. Gold nanoparticles (GNPs) and electroporation (EP) have shown good potential as radiosensitizers for RT. This study aims to investigate the sensitizing effects of EP, GNPs, and combined GNPs-EP on the dose enhancement factor (DEF) for 6 MV photon energy. Methods: Radiosensitizing effects of EP, GNPs, and combinations of GNPs-EP were comparatively investigated in vitro for intestinal colon cancer (HT-29) and Chinese hamster ovary (CHO) cell lines by MTT assay and colony formation assay at 6 MV photon energy in six groups: IR (control group), GNPs+IR, GNPs (24 h)+IR, EP+IR, GNPs+EP+IR, and GNPs (24 h)+EP+IR. Results: Treatment of both cell lines with EP, GNPs, and combined GNPs-EP significantly enhanced the response of cells to irradiation. However, the HT-29 showed higher DEF values for all groups. In addition, the DEF value for HT-29 cells for GNPs+IR, GNPs (24 h)+IR, EP+IR, GNPs+EP+IR, and GNPs (24 h)+EP+IR was, respectively, 1.17, 1.47, 1.36, 2.61, and 2.89, indicating synergistic radiosensitizing effect for the GNPs (24 h)+EP+IR group. Furthermore, the synergistic effect was observed just for HT-29 tumor cell lines. Conclusion: Combined GNPs-EP protocols induced synergistic radiosensitizing effect in HT-29 cells, and the effect is also tumor specific. This combined therapy can be beneficially used for the treatment of intrinsically less radiosensitive tumors.
引用
收藏
页码:1431 / 1439
页数:9
相关论文
共 51 条
[21]  
Jordan C. A., 2013, Electroporation and Electrofusion in Cell Biology
[22]  
Kanduser Masa, 2008, P1, DOI 10.1007/978-0-387-79374-0_1
[23]   Radiosensitization effect of folate-conjugated gold nanoparticles on HeLa cancer cells under orthovoltage superficial radiotherapy techniques [J].
Khoshgard, Karim ;
Hashemi, Bijan ;
Arbabi, Azim ;
Rasaee, Mohammad Javad ;
Soleimani, Masoud .
PHYSICS IN MEDICINE AND BIOLOGY, 2014, 59 (09) :2249-2263
[24]  
Kinosita K., 2012, EVENTS MEMBRANE ELEC
[25]   Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles [J].
Kong, Tao ;
Zeng, Jie ;
Wang, Xiaoping ;
Yang, Xiaoyan ;
Yang, Jing ;
McQuarrie, Steve ;
McEwan, Alexander ;
Roa, Wilson ;
Chen, Jie ;
Xing, James Z. .
SMALL, 2008, 4 (09) :1537-1543
[26]   Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice [J].
Kranjc, S ;
Cemazar, M ;
Grosel, A ;
Sentjurc, M ;
Sersa, G .
BMC CANCER, 2005, 5 (1)
[27]   IODINE CONTRAST-MEDIUM SENSITIZES CULTURED MAMMALIAN-CELLS TO X-RAYS BUT NOT TO GAMMA-RAYS [J].
MATSUDAIRA, H ;
UENO, AM ;
FURUNO, I .
RADIATION RESEARCH, 1980, 84 (01) :144-148
[28]  
Mir LM, 2000, METH MOLEC MED, V37, P99, DOI 10.1385/1-59259-080-2:99
[29]   Gold nanoparticles cellular toxicity and recovery: Effect of size, concentration and exposure time [J].
Mironava, Tatsiana ;
Hadjiargyrou, Michael ;
Simon, Marcia ;
Jurukovski, Vladimir ;
Rafailovich, Miriam H. .
NANOTOXICOLOGY, 2010, 4 (01) :120-137
[30]  
Nishioka A, 1999, ONCOL REP, V6, P583